Document is current
Any future updates will be listed below
-
Authors
Peters, Anju T.
Rolland, Catherine
Lavoie, Louis
Fung, Selwyn
Basoff, Daniel
Chitnis, Abhishek
-
Funding
Funding for this research was provided by:
Insmed
- License Information
-
More Information
Article History
Received: 14 November 2025
Accepted: 16 March 2026
First Online: 30 April 2026
Declarations
:
: Anju T. Peters reports research support from AstraZeneca, Sanofi Regeneron, and Insmed Incorporated. Consultant for AstraZeneca, Sanofi Regeneron, GSK, Chiesi, Eli Lilly, and Insmed Incorporated. Catherine Rolland and Louis Lavoie are employees of PPD™ Evidera™ Health Economics & Market Access, part of Thermo Fisher Scientific, a paid consultant for Insmed Incorporated. Daniel Basoff and Abhishek Chitnis are employees and shareholders of Insmed Incorporated. At the time of this study, Selwyn Fung was an employee of Insmed Incorporated.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
